IRVINE, CA--(Marketwire - November 04, 2009) - Edwards Lifesciences Corporation (NYSE: EW), a
world leader in products and technologies to treat advanced cardiovascular
disease, is scheduled to present at the Credit Suisse Annual Healthcare
Conference at the Arizona Biltmore hotel in Phoenix, Arizona on Wednesday,
November 11, 2009.
Thomas M. Abate, Edwards Lifesciences' corporate vice president, chief
financial officer & treasurer, is scheduled to speak to conference
attendees at 10:30 a.m. MST. A live webcast of the presentation will be
available to all interested parties on the Edwards Lifesciences investor
relations website at
http://www.edwards.com/InvestorRelations/EventCalendar.htm. An archived
version of the webcast will be available later that day on the Edwards
investor relations website in the News and Events section.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves
and hemodynamic monitoring, with more than five decades of experience in
partnering with clinicians to develop life-saving innovations.
Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular
disease with its market-leading heart valve therapies, and critical care
and vascular technologies, which are sold in approximately 100 countries.
The company's global brands include Carpentier-Edwards, Cosgrove-Edwards,
Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz.
Additional company information can be found at http://www.edwards.com.
Edwards is a trademark of Edwards Lifesciences Corporation. Edwards
Lifesciences, the stylized E logo, Carpentier-Edwards, Cosgrove-Edwards,
Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are
trademarks of Edwards Lifesciences Corporation and are registered in the
United States Patent and Trademark Office.
